Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer

Purpose: Standard chemoradiation therapy for stage III non-small cell lung cancer (NSCLCa) results in suboptimal outcomes with a high rate of local failure and poor overall survival. We hypothesize that dose escalation using stereotactic body radiotherapy (SBRT) boost could improve upon these result...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hepel, Jaroslaw T., Peter, Justin, Hiatt, Jessica R., Patel, Salil, Osibanjo, Oluwademilade, Safran, Howard, Curran, Bruce, DiPetrillo, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Research Foundation 2012
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3458262/
https://ncbi.nlm.nih.gov/pubmed/23057009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2012.00124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados